once-daily felodipine as effective and better tolerated than twice-daily nifedipine

1
Reactions 439 - 20 Feb 1993 Once-daily felodipine as effective and better tolerated than twice-daily nifedipine. This was the conclusion of a UK study in which patients with hypertension received extended release felodipine (Plendil ® , Modip ® or Flodil ® ) 5mg once daily or nifedipine (Adalat ® retard) 20mg bid. The BP response rates were similar in both groups, but nifedipine recipients experienced more adverse effects, particularly ankle oedema and flushing, compared with felodipine recipients; adverse effects resulted in treatment withdrawal in 5/40 and 1/37 patients, respectively. Hosie J, et al. Effectiveness and tolerability of felodipine once daily and nifedipine twice daily as monotherapies for mild hypertension. Journal of Drug Development 5: 129-136, Dec 1992 800177901 1 Reactions 20 Feb 1993 No. 439 0114-9954/10/0439-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: buidiep

Post on 17-Mar-2017

214 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Once-daily felodipine as effective and better tolerated than twice-daily nifedipine

Reactions 439 - 20 Feb 1993

■ Once-daily felodipine as effective and bettertolerated than twice-daily nifedipine. This was theconclusion of a UK study in which patients withhypertension received extended release felodipine(Plendil®, Modip® or Flodil®) 5mg once daily ornifedipine (Adalat® retard) 20mg bid. The BP responserates were similar in both groups, but nifedipinerecipients experienced more adverse effects,particularly ankle oedema and flushing, compared withfelodipine recipients; adverse effects resulted intreatment withdrawal in 5/40 and 1/37 patients,respectively.Hosie J, et al. Effectiveness and tolerability of felodipine once daily andnifedipine twice daily as monotherapies for mild hypertension. Journal of DrugDevelopment 5: 129-136, Dec 1992 800177901

1

Reactions 20 Feb 1993 No. 4390114-9954/10/0439-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved